The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System
Abstract
Chronic inflammation is characterized by longstanding microglial activation followed by sustained release of inflammatory mediators, which aid in enhanced nitrosative and oxidative stress. The sustained release of inflammatory mediators propels the inflammatory cycle by increased microglial activation, promoting their proliferation and thus stimulating enhanced release of inflammatory factors. Elevated levels of several cytokines and chronic neuroinflammation have been associated with many neurodegenerative disorders of central nervous system like age-related macular degeneration, Alzheimer disease, multiple sclerosis, Parkinson's disease, Huntington' disease, and tauopathies. This review highlights the basic mechanisms of neuroinflammation, the characteristics of neurodegenerative diseases, and the main immunologic responses in CNS neurodegenerative disorders. A comprehensive outline for the crucial role of microglia in neuroinflammation and neurodegeneration and the role of Toll-like receptor signalling in coexistence of inflammatory mechanisms and oxidative stress as major factors responsible for progression of neurodegeneration have also been presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased biomarkers of oxidative stress (Furman et al., 2016), inflammation and chronic neuroinflammation are reported to be associated with many neurodegenerative disorders of central nervous system (CNS) including AD (Leszek et al., 2016).”
From Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial (2016) · cites this paper as Leszek et al., 2016
Citations
Cites
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
The roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
Guo, C., Sun, L., Chen, X., & Zhang, D. (2013) · PubMed · doi:10.3969/j.issn.1673-5374.2013.21.009 · Cited by 1,371
Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357
Toll‐like Receptor and RIG‐1‐like Receptor Signaling
Kawai, T., & Akira, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.020 · Cited by 1,017
Regulation of innate immune responses in the brain
Rivest, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2565 · Cited by 843
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
Cited by
Sorted by citations
Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00256 · Cited by 946
“Increased biomarkers of oxidative stress (Furman et al., 2016), inflammation and chronic neuroinflammation are reported to be associated with many neurodegenerative disorders of central nervous system (CNS) including AD (Leszek et al., 2016).”
BackgroundInfluentialInflammatory Response in the CNS: Friend or Foe?
Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573
“The long-drawn release of pro-inflammatory mediators propels the inflammatory cycle by increased microglial activation and proliferation, thus stimulating enhanced release of pro-inflammatory agents [75].”
BackgroundSelf-citationTesta, G., Staurenghi, E., Zerbinati, C., Gargiulo, S., Iuliano, L., Giaccone, G., Fantò, F., Poli, G., Leonarduzzi, G., & Gamba, P. (2016) · Redox Biology · doi:10.1016/j.redox.2016.09.001 · Cited by 270
“Besides changes in oxysterol levels, it has also become evident that inflammation and oxidative stress are self-reinforcing during AD progression: inflammation can be triggered or enhanced by oxidative stress, through activation of the redox sensitive transcription factor NF-κB, and vice versa [14,23].”
BackgroundSairazi, N. S. M., & Sirajudeen, K. N. S. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6565396 · Cited by 260
Oxidative Stress and the Microbiota‐Gut‐Brain Axis
Dumitrescu, L., Mitrea, I., Cozma, L., Tulbă, D., Hinescu, M. E., Ceafalan, L. C., Gherghiceanu, M., & Popescu, B. O. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2406594 · Cited by 222
“There is a dual relationship between OS and inflammation: OS can be induced by inflammatory responses, and inflammation can be triggered or enhanced by ROS through activation of nuclear factor-kappa B (NF-κB), which controls the expression of many genes, including some involved in inflammatory responses leading to the…”
Background3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases
Bandookwala, M., & Sengupta, P. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1713776 · Cited by 194
Jurado-Coronel, J. C., Cabezas, R., Ávila Rodríguez, M. F., Echeverria, V., García-Segura, L. M., & Barreto, G. E. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.09.002 · Cited by 180
“Oxidative stress, excitotoxicity and neuroinflammation play an important role in neuronal death in PD (Albarracin et al., 2012; Leszek et al., 2016; Sutachan et al., 2012; Cabezas et al., 2014), being important the involvement of nitric oxide (NO) and other reactive nitrogen species (Fukae et al.”
BackgroundRahman, M. H., Bajgai, J., Fadriquela, A., Sharma, S., Trinh, T. T., Akter, R., Jeong, Y. J., Goh, S. H., Kim, C.-S., & Lee, K.-J. (2021) · Molecules · doi:10.3390/molecules26175327 · Cited by 182
“Furthermore, the pathophysiology of NDs can also include neuroinflammation [34,35].”
BackgroundAnsari, F., Pourjafar, H., Tabrizi, A., & Homayouni, A. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200107113812 · Cited by 170
Role of the peripheral innate immune system in the development of Alzheimer's disease
Page, A. Y. L., Dupuis, G., Frost, E. H., Larbi, A., Pawelec, G., Witkowski, J. M., & Fülöp, T. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.019 · Cited by 162
“This feedback loop between brain and periphery establishes a continuous cross-talk between these two compartments (Holmes et al., 2003; Leszek et al., 2016; Blach-Olszewska et al., 2015; Busse et al., 2017).”
Rizor, A., Pajarillo, E. A. B., Johnson, J., Aschner, M., & Lee, E.-S. (2019) · Antioxidants · doi:10.3390/antiox8080265 · Cited by 165
“Although reactive astrocytes contribute to limiting CNS damage during acute injury, prolonged astrogliosis leads to neurotoxicity [46].”
BackgroundThe Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations
Li, X., Feng, Y., Wang, X.-X., Truong, D., & Wu, Y. (2020) · Aging and Disease · doi:10.14336/ad.2020.0216 · Cited by 134
“no doubt that neuroinflammation plays a role in the progression of PD [85].”
BackgroundPiirainen, S., Youssef, A. M., Song, C., Kalueff, A. V., Landreth, G. E., Malm, T., & Tian, L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.046 · Cited by 130
“Various physiological and cellular stressors, including aging and ypoxia, can “prime” microglia and exacerbate neuroinflammation n AD, as reviewed elsewhere (Head et al., 2016; Heikkinen et al., 014; Leszek et al., 2016; Song et al., 2016).”
Peroxisomes in Immune Response and Inflammation
Cara, F. D., Andreoletti, P., Trompier, D., Véjux, A., Bülow, M. H., Sellin, J., Lizard, G., Cherkaoui‐Malki, M., & Savary, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163877 · Cited by 134
“Given the role that peroxisomes play in oxidative stress, there is growing evidence that suggest that peroxisomes have similar contributions to pathophysiological features in other neurodegenerative diseases such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and Huntington’s disease, in which high l…”
BackgroundIn Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
Gugliandolo, A., Pollastro, F., Grassi, G., Bramanti, P., & Mazzon, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071992 · Cited by 119
“Indeed, inflammatory cells can produce reactive species at the site of inflammation causing oxidative stress, while reactive oxygen/nitrogen species may initiate an intracellular signaling cascade that induces the expression of pro-inflammatory genes [15,19].”
BackgroundRAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration
Gąsiorowski, K., Brokos, B., Echeverrı́a, V., Barreto, G. E., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0419-4 · Cited by 120
Self-citationInducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
Chandran, V., Gao, K., Swarup, V., Versano, R., Dong, H., Jordan, M. C., & Geschwind, D. H. (2017) · eLife · doi:10.7554/elife.30054 · Cited by 103
“This implicates a vital role for chemokines and 244 immune response in FRDA pathology, as has been suggested for other neurodegenerative 245 diseases(45-48).”
BackgroundCobourne-Duval, M. K., Taka, E., Mendonca, P., & Soliman, K. F. A. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.04.018 · Cited by 94
Ser, H., Tan, L. T., Palanisamy, U. D., Malek, S. N. A., Yin, W., Chan, K., Goh, B. H., & Lee, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00899 · Cited by 94
“In recent years, the accumulation of free radicals or oxidative stress has been identified as one of the major contribution to neuronal loss and occur early in all major neurodegenerative diseases (Lin and Beal, 2006; Fischer and Maier, 2015; Leszek et al., 2016).”
BackgroundFractalkine Modulates Microglia Metabolism in Brain Ischemia
Lauro, C., Chece, G., Monaco, L., Antonangeli, F., Peruzzi, G., Rinaldo, S., Paone, A., Cutruzzolà, F., & Limatola, C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00414 · Cited by 91
Cerium Oxide Nanoparticles: Recent Advances in Tissue Engineering
Hosseini, M., & Mozafari, M. (2020) · Materials · doi:10.3390/ma13143072 · Cited by 95
Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
Chen, Q.-Q., Haikal, C., Li, W., & Li, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00218 · Cited by 88
Focused Review: Cytotoxic and Antioxidant Potentials of Mangrove-Derived Streptomyces
Ser, H., Tan, L. T., Law, J. W., Chan, K., Duangjai, A., Saokaew, S., Pusparajah, P., Mutalib, N. A., Khan, T. M., Goh, B. H., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02065 · Cited by 86
“, Parkinson’s disease and Alzheimer’s disease), cardiovascular diseases and also cancer (Gemma et al., 2007; Abdollahi et al., 2014; Fischer and Maier, 2015; Leszek et al., 2016).”
BackgroundDenver, P., & McClean, P. L. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238608 · Cited by 89
“…microglial activation and unresolved inflammation in the brain is harmful to neurons and synapses and promotes a state of chronic dysregulation of glial cells and subsequent deterioration of brain structure and function (Frank-Cannon et al., 2009; Steardo et al., 2015; Leszek et al., 2016).”
BackgroundSelvaraj, K., Ravichandran, S., Krishnan, S., Radhakrishnan, R. K., Manickam, N., & Kandasamy, M. (2021) · Reproductive Sciences · doi:10.1007/s43032-020-00441-x · Cited by 87
Jeon, M.-T., Kim, K.-S., Kim, E. S., Lee, S., Kim, J., Hoe, H.-S., & Kim, D.-G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101333 · Cited by 76
“Infiltrating macrophages contribute to oxidative stress and neuroinflammation by producing ROS, nitric oxide, and pro-inflammatory cytokines in brains with NDs, such as stroke, PD and AD (Gesuete et al., 2016; Leszek et al., 2016).”
BackgroundInflammation, insulin signaling and cognitive function in aged APP/PS1 mice
Denver, P., English, A. R., & McClean, P. L. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.032 · Cited by 80
López‐Cerdán, A., Andreu, Z., Hidalgo, M. R., Grillo-Risco, R., Català-Senent, J. F., Soler-Sáez, I., Neva-Alejo, A., Gordillo, F., de la Iglesia-Vayá, M., & Garcia‐García, F. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00477-5 · Cited by 77
“Oxidative stress, excitotoxicity, and neuroinflammation influence neuron death in PD [5, 6], while nitric oxide and other reactive nitrogen species [7, 8] promote PD progression.”
BackgroundRelationship Between Obesity, Alzheimer’s Disease, and Parkinson’s Disease: an Astrocentric View
Martín-Jiménez, C., Gaitán-Vaca, D. M., Echeverría, V., González, J., & Barreto, G. E. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0193-8 · Cited by 80
Redox Signaling, Neuroinflammation, and Neurodegeneration
Aguilera, G., Colín-González, A. L., Rangel‐López, E., Chavarría, A., & Santamaría, A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7099 · Cited by 81
The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer’s Disease
Gamba, P., Giannelli, S., Staurenghi, E., Testa, G., Sottero, B., Biasi, F., Poli, G., & Leonarduzzi, G. (2021) · Antioxidants · doi:10.3390/antiox10050740 · Cited by 70
“Of note, it has been widely reported that increased oxidative stress in the AD brain intensifies neurodegeneration by favoring generation of reactive oxygen species (ROS) and lipid peroxidation [8,9].”
BackgroundThe Pathophysiology of Nitrogen Dioxide During Inhaled Nitric Oxide Therapy
Petit, P. C., Fine, D. H., Vásquez, G. B., et al. (2016) · ASAIO Journal · doi:10.1097/mat.0000000000000425 · Cited by 75
Sochocka, M., Sobczyński, M., Sender-Janeczek, A., Zwolińska, K., Błachowicz, O., Tomczyk, T., Ziętek, M., & Leszek, J. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170316163340 · Cited by 80
“Inflammation and pro-inflammatory mediators, blood vessel damage, and oxidative stress have been found to be capable of inducing neurodegeneration, resulting in neuronal loss and brain injury [10, 12-14].”
Self-citationKenawy, S. M., Hegazy, R. R., Hassan, A. H. M., El-Shenawy, S. M. A., Gomaa, N., Zaki, H. F., & Attia, A. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183565 · Cited by 76
Antidiabetic potential of saffron and its active constituents
Yaribeygi, H., Zare, V., Butler, A. E., Barreto, G. E., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27843 · Cited by 74
“…stress is a consequence of an imbalance between free radical species and the antioxidant defense system in favor of free radicals (Alexiou et al., 2018; Cabezas, El ‐ Bachá, González & Barreto, 2012; Leszek et al., 2016; Sutachan et al., 2012; Yaribeygi, Faghihi, Mohammadi, & Sahebkar, 2018).”
Chu, C., Yu, L., Li, Y. H., Guo, H., Zhai, Q., Chen, W., & Tian, F. (2023) · Nutrients · doi:10.3390/nu15071737 · Cited by 71
“Reducing oxidative stress, as one of the pathogenic mechanisms of PD, has emerged as one of numerous novel pharmacological therapies that may provide new avenues for PD treatment [5].”
BackgroundMyelin in Alzheimer’s disease: culprit or bystander?
Maitre, M., Jeltsch-David, H., Okechukwu, N. G., Klein, C., Patte-Mensah, C., & Mensah-Nyagan, A.-G. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01554-5 · Cited by 66
Adetuyi, B. O., & Farombi, E. O. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13660 · Cited by 71
Cansız, D., Ünal, İ., Üstündağ, Ü. V., Alturfan, A. A., Altinoz, M. A., Elmacı, İ., & Emekli‐Alturfan, E. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06532-5 · Cited by 69
Kim, J.-E., Lee, H., Park, J., Cha, B., & Hoe, H. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02549-0 · Cited by 74
“Superoxide dismutase 2 (SOD2), a major antioxidant enzyme in mitochondria, is reportedly induced in the CNS under various neuroinflammatory conditions [17].”
BackgroundInfluentialXie, J., Hong, E., Ding, B., Jiang, W., Zheng, S., Xie, Z., Tian, D., & Chen, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.578060 · Cited by 72
“Bax, an apoptotic counterpart to bcl-2, can antagonize bcl-2, and the relative ratio between Bax and bcl-2 is a key factor in determining the degree of inhibition of apoptosis (Li et al., 2018).”
BackgroundHidalgo‐Lanussa, O., Ávila-Rodriguez, M., Báez-Jurado, E., Zamudio-Rodriguez, J. A., Echeverría, V., García‐Segura, L. M., & Barreto, G. E. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0777-y · Cited by 67
Urrutia, P. J., Hirsch, É. C., González-Billault, C. E., & Núñez, M. T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14005 · Cited by 68
“Inflammation and oxidative stress are common features of neurodegenerative diseases of the central nervous system, such asADandParkinson’s disease (Fischer andMaier 2015; Leszek et al. 2016).”
BackgroundXu, Y., Cui, C., Sun, M., Zhu, Y., Chu, M., Shi, Y., Lin, S. L., Yang, X., & Shen, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26010 · Cited by 65
“P disease (PD) is a neurodegenerative disease characterized by progressive loss of dopaminergic neurons in the substantia nigra (SN), leading to clinical symptoms such as resting tremor, bradykinesia, postural instability, and attitudinal reflex deficiency [Lotharius and Brundin, 2002; Dauer and Przedborski, 2003], wh…”
BackgroundHilliard, A. L., Mendonca, P., & Soliman, K. F. A. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577269 · Cited by 64
“However, chronic neuroinflammation tends to cause more neuronal damage and eventual degradation (Kempuraj et al., 2016; Leszek et al., 2016; Cobourne-Duval et al., 2018).”
Ashraf, J. M., Ansari, M. A., Fatma, S., Abdullah, S. M., Iqbal, J., Madkhali, A. M., Hamali, H. A., Ahmad, S., Jerah, A. A., Echeverrı́a, V., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0935-x · Cited by 60
“Carboxymethyl lysine (CML) content was measured by ELISA as described earlier, with minor modification [34].”
MethodMajkutewicz, I., Kurowska, E., Podlacha, M., Myślińska, D., Grembecka, B., Ruciński, J., Pierzynowska, K., & Wrona, D. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.016 · Cited by 58
Oxidative Stress in Poultry and the Therapeutic Role of Herbal Medicine in Intestinal Health
Li, Y., Wang, K., & Li, C. (2024) · Antioxidants · doi:10.3390/antiox13111375 · Cited by 57
“…increasing the intestinal permeability, with the disruption of tight junction proteins [40]. toxic ROS metabolites produced by intestinal cells can disrupt the microecological balance of the intestine by activating NF-κ B, producing various cytokines and triggering an inflammatory response [44].”
Astrocytes and endoplasmic reticulum stress: A bridge between obesity and neurodegenerative diseases
Martín-Jiménez, C., García-Vega, Á. S., Cabezas, R., Aliev, G., Echeverrı́a, V., González, J., & Barreto, G. E. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.001 · Cited by 56
“One of the studied relationships between astrocytes in the pathogenesis of neurodegenerative diseases involves Toll-like receptors (TLRs) signaling (Blach-Olszewska et al., 2015; Gasiorowski et al., 2017; Leszek et al., 2016).”
BackgroundSelf-citationMorshedi, M., Bavafa-Valenlia, K., Hosseinifard, E.-S., Shahabi, P., Abbasi, M. M., Ghorbani, M., Barzegari, A., Sadigh‐Eteghad, S., & Saghafi‐Asl, M. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.022 · Cited by 52
LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation
Yan, R., & Liu, Z. (2016) · Protein & Cell · doi:10.1007/s13238-016-0326-x · Cited by 51
“In addition, there are extensive reports in the literature suggesting that dysregulated inflammation is involved in the development of Parkinson’s disease (Leszek et al., 2016).”
BackgroundChi, H., Cao, W., Zhang, M., Su, D., Yang, H., Li, Z., Li, C., She, X., Wang, K., Gao, X., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02053-3 · Cited by 49
“The noise exposure procedure followed the method reported in our previous work [19].”
BackgroundMethodThe Role of Cyclo(His-Pro) in Neurodegeneration
Grottelli, S., Ferrari, I., Pietrini, G., Peirce, M. J., Minelli, A., & Bellezza, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081332 · Cited by 47
Stress and Alzheimer’s disease: A senescence link?
Lyons, C. E., & Bartolomucci, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.010 · Cited by 49
Shou, J., & Shaw, P. (2022) · Cells · doi:10.3390/cells11050796 · Cited by 48
“While inflammation and oxidative stress consist of distinct biochemical cascades, the processes are closely intertwined and function in parallel [154].”
BackgroundGarcinol, a multifaceted sword for the treatment of Parkinson's disease
Deb, S., Phukan, B. C., Mazumder, M. K., Dutta, A., Paul, R. K., Bhattacharya, P., Sandhir, R., & Borah, A. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.004 · Cited by 46
Mazumder, M. K., Choudhury, S., & Borah, A. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.05.003 · Cited by 44
“The major sources of the RONS are the NADPH oxidase, xanthine oxidase and mitochondria, and thus mitochondrial dysfunctions have been reported to cause OS and neurodegeneration in animal models of PD and AD (Beal, 2005; Jiang et al., 2016; Kim et al., 2015; Subramaniam and Chesselet, 2013; Lipski et al., 2011; Leszek…”
BackgroundThe Role of Formyl Peptide Receptors in Neurological Diseases via Regulating Inflammation
Zhu, J., Li, L., Ding, J., Huang, J., Shao, A., & Tang, B. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.753832 · Cited by 44
Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics
Abreu, C. M., Soares-dos-Reis, R., Melo, P., Relvas, J. B., Guimarães, J., Sá, M. J., Cruz, A., & Pinto, I. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00164 · Cited by 42
“…regulating the activity of the transcription factors AP1 and NF-κB, which in turn control the production and release of inflammatory mediators, such as the cytokines TNFα, IL-1β, IL-6, and IL-8, reactive oxygen and nitrogen species (Ortiz et al., 2013; Leszek et al., 2016; Labzin et al., 2018).”
BackgroundAnderson, G., & Maes, M. H. J. (2017) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666161122144659 · Cited by 41
Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds
Hidalgo‐Lanussa, O., Báez-Jurado, E., Echeverría, V., Ashraf, G. M., Sahebkar, A., García‐Segura, L. M., Melcangi, R. C., & Barreto, G. E. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12776 · Cited by 42
Trojan, E., Bryniarska, N., Leśkiewicz, M., Regulska, M., Chamera, K., Szuster-Głuszczak, M., Leopoldo, M., Lacivita, E., & Basta‐Kaim, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191019170244 · Cited by 42
Jia, Y., Zhang, D., Li, H., Luo, S., Xiao, Y., Li, H., Zhou, F., Wang, C., Feng, L., Wang, G., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114422 · Cited by 41
Ahmed, M. M., Johnson, N. R., Boyd, T. D., Coughlan, C. M., Chial, H. J., & Potter, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.718426 · Cited by 42
Dominiak, A., Wilkaniec, A., Jęśko, H. M., Czapski, G. A., Lenkiewicz, A. M., Kurek, E., Wroczyński, P., & Adamczyk, A. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.02.014 · Cited by 40
“Immune activation within the central nervous system (CNS) is involved in the pathogenesis of many neurodegenerative diseases, including Alzheimer's or Parkinson's diseases as well as various neuropsychiatric disorders, like autism (Chez et al., 2007; Leszek et al., 2016; Li et al., 2009; Pasqualetti et al., 2015).”
Petkau, T. L., Hill, A., Connolly, C., Lu, G., Wagner, P., Kosior, N., Blanco, J., & Leavitt, B. R. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz009 · Cited by 37
Deng, S., Ai, Y., Gong, H., Feng, Q., Li, X., Chen, C., Liu, Z., Wang, Y., Peng, Q., & Zhang, L. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.136 · Cited by 39
Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy
LeBlang, C. J., Medalla, M., Nicoletti, N. W., Hays, E. C., Zhao, J., Shattuck, J. E., Cruz, A. L., Wolozin, B. L., & Luebke, J. I. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00285 · Cited by 38
Nie, Y., Yang, J., Zhou, L., Yang, Z., Liang, J., Liu, Y., Ma, X., Qian, Z., Hong, P., Kalueff, A. V., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02403-3 · Cited by 39
L-linalool exerts a neuroprotective action on hemiparkinsonian rats
de Lucena, J. D., Gadelha-Filho, C. V. J., da Costa, R. O., de Araújo, D. P., Lima, F. A. V., Neves, K. R. T., & Viana, G. S. D. B. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01793-1 · Cited by 42
“In conclusion, considering that neuroinflammation and oxidative stress play key roles on the neuropathological features of PD (Mosley et al. 2006; Taylor et al. 2013; Leszek et al. 2016) and that LIN exerts both anti-inflammatory and antioxidant actions, our results strongly suggest that LIN neuroprotective activity i…”
Tylek, K., Trojan, E., Leśkiewicz, M., Regulska, M., Bryniarska, N., Curzytek, K., Lacivita, E., Leopoldo, M., & Basta‐Kaim, A. (2021) · Cells · doi:10.3390/cells10092373 · Cited by 37
Wei, T., Wang, Y., Xu, W., Liu, Y., Chen, H., & Yu, Z. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104588 · Cited by 33
Alzheimer’s disease: review of current nanotechnological therapeutic strategies
Baranowska‐Wójcik, E., & Szwajgier, D. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1719069 · Cited by 35
Regulska, M., Szuster-Głuszczak, M., Trojan, E., Leśkiewicz, M., & Basta‐Kaim, A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200807144530 · Cited by 62
“Therefore, these data indicate that the resolution of inflammatory response is a multistage and active process [50], and the failure of one or more steps may be involved in the prolonged inflammation and the pathogenesis of chronic inflammatory diseases due to constant stimulation of the immune system, increased pro-i…”
BackgroundPalomares, T., Cordero, M., Bruzos-Cidón, C., Torrecilla, M., Ugedo, L., & Alonso‐Varona, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0714-0 · Cited by 34
“Nowadays, neuroinflammation, along with one of its main intrinsic features, oxidative stress, is considered one of most important pathophysiological explanations for the development and progression of neurodegenerative diseases [1, 2].”
BackgroundChiaravalloti, A., Fiorentini, A., Ursini, F., Martorana, A., Koch, G., Belli, L., Toniolo, S., Pietro, B. D., Motta, C., & Schillaci, O. (2016) · Medicine · doi:10.1097/md.0000000000004206 · Cited by 32
“On the other side, the identification of intratechal-synthesized Ig could represent only the epiphenomenon of the presence of deranged immune cells inside the CNS, and these cells contributing to neuropathology with Ig-independent mechanisms.([15]) Contrarily to Qalb, the percentage of AD subjects showing alterations…”
BackgroundMartorana, F., Foti, M., Virtuoso, A., Gaglio, D., Aprea, F., Latronico, T., Rossano, R., Riccio, P., Papa, M., Alberghina, L., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8056904 · Cited by 31
“Nevertheless, chronic astrocytic activation (reactive gliosis) may hold deleterious consequences that limit functional repair of brain parenchyma [4, 6, 7].”
BackgroundAnti-oxidative activity of probiotics; focused on cardiovascular disease, cancer, aging, and obesity
Kavyani, B., Ahmadi, S., Nabizadeh, E., & Abdi, M. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107001 · Cited by 31
Geng, L., Liu, W., & Chen, Y. (2019) · Journal of Biological Research - Thessaloniki · doi:10.1186/s40709-019-0102-1 · Cited by 29
Wiatrak, B., & Balon, K. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02204-w · Cited by 27
Loughman, A., Adler, C. J., & Macpherson, H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220760 · Cited by 26
“Microglial activation is a central component of the neuroinflammatory cascade leading to cognitive decline in AD [69].”
BackgroundPutative neural consequences of captivity for elephants and cetaceans
Jacobs, B., Rally, H., Doyle, C., O’Brien, L., Tennison, M., & Marino, L. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0100 · Cited by 25
“One neural consequence under such conditions is microglia activation and a sustained release of inflammatory mediators (Leszek et al. 2016).”
BackgroundTaurine counteracts the neurotoxic effects of streptozotocin-induced diabetes in rats
Caletti, G., Herrmann, A. P., Pulcinelli, R. R., Reinhardt, L. S., Morás, A. M., Vianna, P., Chies, J. A. B., Moura, D. J., Barros, H. M. T., & Gomez, R. (2017) · Amino Acids · doi:10.1007/s00726-017-2495-1 · Cited by 25
Tan, X., Zhou, Y., Gong, P., Guan, H., Wu, B., Hou, L., Feng, X., Zheng, W., & Li, J. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.12.014 · Cited by 22
Oxidative Stress Assessment in Alzheimer’s Disease: A Clinic Setting Study
Vergallo, A., Giampietri, L., Baldacci, F., Volpi, L., Chico, L., Pagni, C., Giorgi, F. S., Ceravolo, R., Tognoni, G., Siciliano, G., et al. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517728352 · Cited by 24
Fournier, C. N., Houser, M. C., Tansey, M. G., Glass, J. D., & Hertzberg, V. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.007 · Cited by 21
Zhao, H., Cheng, J., Liu, T., Jiang, J., Koch, F. C., Sachdev, P. S., Basser, P. J., Wen, W. X., & Initiative, A. D. N. (2021) · Human Brain Mapping · doi:10.1002/hbm.25628 · Cited by 19
“Axonal loss and glial swelling are prominent features of AD (Englund, 1998; Stokin et al., 2005), this may lead to the enlarged perivascular spaces in the pathogenesis of AD (Fischer & Maier, 2015; Kawahara, 2010; Leszek et al., 2016; Reddy, 2009; Santos et al., 2010; Shu et al., 2013).”
Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder
Mendoza, C., Barreto, G. E., Iarkov, A., Tarasov, V. V., Aliev, G., & Echeverrı́a, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0869-3 · Cited by 22
Self-citationNeshan, M., Malakouti, S. K., Kamalzadeh, L., Makvand, M., Campbell, A., & Ahangari, G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210480 · Cited by 19
Mohamad, H. E., Abo–Elmatty, D. M., Wahba, N. S., Shaheen, M. A., Sakr, R., & Wahba, A. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120613 · Cited by 20
Forte, A. R. C. C., Lessa, P. H. C., Filho, A. J. M. C., de Aquino, P. E. A., Brito, L. M., PINHEIRO, L. C. S., Juruena, M. F., de Lucena, D. F., de Rezende, P. H. F., & Vasconcelos, S. M. M. (2023) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2023e12484 · Cited by 24
“On the other hand, inflammation can be triggered or enhanced by oxidative stress through activation of nuclear factor-kappa B (NF-kB), which controls the expression of many genes, including inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2), which are involved in proinflammatory cytokine production (68…”
BackgroundProbiotics that Ameliorate Cognitive Impairment through Anti-Inflammation and Anti-Oxidation in Mice
Lee, S., Eom, S., Lee, J., Pyeon, M., Kim, K., Choi, K. Y., Lee, J., Shin, D. J., Lee, K. H., Oh, S., et al. (2023) · Food Science of Animal Resources · doi:10.5851/kosfa.2023.e22 · Cited by 18
Gut microbiota influence frailty syndrome in older adults: mechanisms and therapeutic strategies
Wang, X., Fan, L., Meng, C., Wang, Y., Deng, L.-E., Yuan, Z., Zhang, J., Li, Y., & Lv, S. (2023) · Biogerontology · doi:10.1007/s10522-023-10082-7 · Cited by 20
“ROS can also trigger or enhance inflammation through direct activation of NF-κB (Leszek et al. 2016).”
Wakulik, K., Wiatrak, B., Szczukowski, Ł., Bodetko, D., Szandruk-Bender, M., Dobosz, A., Świątek, P., & Gąsiorowski, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072575 · Cited by 19
Self-citationLiu, J., Hui, A., Wang, J., Hu, Q., Li, S., Chen, Y., Wu, Z., & Zhang, W. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110675 · Cited by 17
Asejeje, F. O., Abiola, M. A., Adeyemo, O. A., Ogunro, O. B., & Ajayi, A. M. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137710 · Cited by 18
Signoriello, E., Mallardo, M., Nigro, E., Polito, R., Casertano, S., Pietro, A. D., Coletta, M., Monaco, M. L., Rossi, F., Lus, G., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02287-z · Cited by 17
Asghari, A., Hosseini, M., Beheshti, F., Shafei, M. N., & Mehri, S. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1480602 · Cited by 17
“A relationship between oxidative stress and neuroinflammation and their contribution in neurodegeneration have been widely suggested [64,65].”
BackgroundRather, M. A., Khan, A., Jahan, S., Siddiqui, A. J., & Wang, L. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.042 · Cited by 18
The human body as an energetic hybrid? New perspectives for chronic disease treatment?
Gajewski, M., Rzodkiewicz, P., & Maśliński, S. (2017) · Reumatologia/Rheumatology · doi:10.5114/reum.2017.67605 · Cited by 15
“This observation links oxidative stress with the development of neuronal death and neural dysfunction [16, 17].”
Background
Metadata
- Authors
- Leszek, J., E. Barreto, G., G|siorowski, K., Koutsouraki, E., Ávila-Rodrigues, M., & Aliev, G.
- Venue
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2016-03-10
- Volume
- 15
- Issue
- 3
- Pages
- 329-336
- ISSN
- 1568-007X (ISSN-L)
- 1871-5273
- OpenAlex
- W2271123303
- Semantic Scholar
- 91475bee1cf3d32abe2d7e1be1755b559ca3dc93
- Cited by
- 206
- References
- 88
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 23 · 2023: 16 · 2022: 13 · 2021: 23 · 2020: 20 · 2019: 16 · 2018: 31 · 2017: 23 · 2016: 9
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS & Neurological Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- neuroinflammation, neurodegeneration, microglial activation, oxidative stress, nitrosative stress, Toll-like receptor signaling, cytokines, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, age-related macular degeneration, tauopathy
- MeSH terms
- Animals, Brain, Humans, Immunity, Innate, Inflammation, Cytokines, Microglia, Oxidative Stress, Disease Progression, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review